Therasid Bioscience mainly deals with new chemical entities as a treatment for drug discovery and development. But we also pursue gene therapy and biologics, as well as cell therapy in the view of indication focused approaches, meaning not only using in-house technology for development of intervention but also being open to external technology.
We are building a novel liver disease related platform which contains liver cell components(hepatocyte, kupffer cell and hepatic stellate cell) with academia for drug discovery and development. We have aleady built ganglioside-based disease approaching system for covering various kinds of unmet needed disease including neurodegenerative disease. For initiation of drug discovery, we also use molecular modeling which can hit molecules and facilitate lead optimization.